You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

oral squamous cell carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Oral Squamous Cell Carcinoma, Oral Mucositis Trial in Guangzhou (Alfacalcidol Oral Solution, Placebo)

Recruiting
  • Oral Squamous Cell Carcinoma
  • Oral Mucositis
  • Alfacalcidol Oral Solution
  • Placebo
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital
Aug 24, 2023

Oral Cancer, Oral Squamous Cell Carcinoma Trial in Fayoum (ELISA)

Recruiting
  • Oral Cancer
  • Oral Squamous Cell Carcinoma
  • ELISA
  • Fayoum, Egypt
    Fayoum University
Sep 8, 2023

WORST PATTERN OF INVASION IN ORAL SQUAMOUS CELL CARCINOMA

Recruiting
  • Oral Cancer
  • +2 more
  • Biopsy Specimens Histopathology
  • Rawalpindi, Punjab, Pakistan
    Armed Forces Institute of Pathology
Jun 22, 2023

Salivary LINC00657 asDiagnostic Biomarker for Oral Squamous Cell

Completed
  • Oral Squamous Cell Carcinoma
    • Fayoum, Egypt
      faculty of dentistry, Fayoum university
    Apr 19, 2023

    Oral Squamous Cell Carcinoma, Neck Dissection Trial (Elective neck dissection, Therapeutic neck dissection)

    Not yet recruiting
    • Oral Squamous Cell Carcinoma
    • Neck Dissection
    • Elective neck dissection
    • Therapeutic neck dissection
    • (no location specified)
    Apr 10, 2023

    Oral Squamous Cell Carcinoma Trial (Three-Week Treatment Regimen with Trastuzumab in Combination with Docetaxel and Platinum

    Not yet recruiting
    • Oral Squamous Cell Carcinoma
    • Three-Week Treatment Regimen with Trastuzumab in Combination with Docetaxel and Platinum Triple Therapy
    • (no location specified)
    Nov 11, 2023

    Oral Squamous Cell Carcinoma Trial in Beijing (Toripalimab)

    Not yet recruiting
    • Oral Squamous Cell Carcinoma
    • Beijing, China
      Peking Union Medical College Hospital, Chinese Academy of Medica
    Apr 5, 2023

    Oral Squamous Cell Carcinoma Trial (Tislelizumab, Albumin paclitaxel, Cisplatin)

    Not yet recruiting
    • Oral Squamous Cell Carcinoma
    • (no location specified)
    May 7, 2023

    Oral Cancer, PD-1 Trial in Guangzhou (PD-1 with chemo, upright surgery)

    Recruiting
    • Oral Cancer
    • PD-1
    • PD-1 with chemotherapy
    • upright surgery
    • Guangzhou, Guangdong, China
      Sun yat-sen memorial hospital
    Nov 12, 2023

    Oral Squamous Cell Carcinoma Trial (PRV211 (Intraoperative Cisplatin System))

    Not yet recruiting
    • Oral Squamous Cell Carcinoma
    • PRV211 (Intraoperative Cisplatin System)
    • (no location specified)
    May 30, 2023

    Oral Squamous Cell Carcinoma Trial in Wuhan (Camrelizumab plus TP, TP)

    Not yet recruiting
    • Oral Squamous Cell Carcinoma
    • Camrelizumab plus TP
    • TP
    • Wuhan, Hubei, China
      Hospital of Stomatology, Wuhan University
    Mar 22, 2023

    People Living With HIV, Oral and Oropharyngeal Cancer, and

    Not yet recruiting
    • HIV Infections
    • +2 more
    • Group Meeting (Focus Group)
    • Questionnaires
    • San Francisco, California
      University of California, San Francisco
    Sep 20, 2023

    Neoadjuvant Pembrolizumab in III-IVA Resectable Oral Squamous

    Recruiting
    • Oral Cavity Squamous Cell Carcinoma
    • Guangzhou, Guangdong, China
      Liuxiqiang
    Feb 1, 2023

    Oral Squamous Cell Carcinoma Trial in Tampere (Punch biopsy)

    Recruiting
    • Oral Squamous Cell Carcinoma
    • Punch biopsy
    • Tampere, Pirkanmaa, Finland
      Tampere University Hospital
    Jun 5, 2023

    Oral Squamous Cell Carcinoma Trial in Shanghai (Camrelizumab Plus Docetaxel and Cisplatin)

    Recruiting
    • Oral Squamous Cell Carcinoma
    • Camrelizumab Plus Docetaxel and Cisplatin
    • Shanghai, Shanghai, China
      Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Ton
    Nov 9, 2022

    The Long Non Coding MALAT1 asPotential Salivary Diagnostic

    Completed
    • Oral Cancer Biomarkers
      • Giza, Egypt
        Rania Hassan Shalby
      Jan 31, 2023

      TPExtreme Induced Chemotherapy Followed by Surgery and

      Recruiting
      • Oral Squamous Cell Carcinoma
      • Locally Advanced Head and Neck Squamous Cell Carcinoma
      • Modified radical surgery
      • Radical surgery
      • Changsha, Hunan, China
        Xiangya Hospital, Central South University
      May 14, 2023

      Oral Squamous Cell Carcinoma, Maxillo-facial Surgery, Biomarkers Trial in Amiens (saliva tube)

      Recruiting
      • Oral Squamous Cell Carcinoma
      • +5 more
      • saliva tube
      • Amiens, Picardie, France
        Amiens University Hospital
      Mar 17, 2023

      Oral Squamous Cell Carcinoma Trial in Wuhan (Camrelizumab, Camrelizumanb plus TPF)

      Active, not recruiting
      • Oral Squamous Cell Carcinoma
      • Wuhan, Hubei, China
        Hospital of Stomatology, Wuhan University
      Aug 17, 2022

      Postoperative Radiotherapy for Oral Squamous Cell Carcinoma

      Recruiting
      • Radiotherapy
      • +3 more
        • Shanghai, Shanghai, China
          Ninth People's Hospital, Shanghai Jiao Tong University School of
        Jul 12, 2022

        Oral Squamous Cell Carcinoma, Neoadjvant Therapy, Anti-PD-1 Trial in Shanghai (Camrelizumab (anti-PD-1 inhibitor), Apatinib

        Recruiting
        • Oral Squamous Cell Carcinoma
        • +3 more
        • Camrelizumab (anti-PD-1 inhibitor)
        • Apatinib (anti-VEGFR inhibitor)
        • Shanghai, Shanghai, China
          Ninth People's Hospital, Shanghai Jiao Tong University School of
        Oct 8, 2022

        Oral Squamous Cell Carcinoma, Neoadjvant Therapy, Anti-PD-1 Trial in Shanghai (Toripalimab (anti-programmed death-1 inhibitor),

        Recruiting
        • Oral Squamous Cell Carcinoma
        • +3 more
        • Toripalimab (anti-programmed death-1 inhibitor)
        • +4 more
        • Shanghai, Shanghai, China
          Ninth People's Hospital, Shanghai Jiao Tong University School of
        Oct 8, 2022

        Mouth Tumors, Carcinoma, Squamous Cell Trial in Shanghai (drug, procedure, radiation)

        Recruiting
        • Mouth Neoplasms
        • Carcinoma, Squamous Cell
        • TPF group
        • +2 more
        • Shanghai, Shanghai, China
          Ninth People's Hospital, Shanghai Jiao Tong University School of
        Oct 5, 2022

        Oral Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma Trial in China (Tislelizumab, Albumin-Bound Paclitaxel,

        Recruiting
        • Oral Squamous Cell Carcinoma
        • Oropharyngeal Squamous Cell Carcinoma
        • Beijing, Beijing, China
        • +13 more
        Aug 22, 2023

        Oral Microbioma and Oral Malignant Disease

        Recruiting
        • Oral Cancer
        • +2 more
          • Maastricht, Netherlands
          • +1 more
          Mar 10, 2023